Online Program

New Framework and measures to build a culture of health – the CDC perspective

Tuesday, November 3, 2015 : 12:50 p.m. - 1:10 p.m.

John Auerbach, MBA, Centers for Disease Control and Prevention, Atlanta, GA

The Robert Wood Johnson Foundation has worked over the past year, in collaboration with the RAND Corporation, to develop a Framework and set of Measures that support a national strategy and movement to Build a Culture of Health. One research question drove the development of a framework and set of 41 national measures: "What is holding our nation back from the health and health equity that we aspire to?" As a nation we are not addressing the interdependence of the many social, economic, physical, environmental, and spiritual factors of health and well-being. Measures that motivate achieving equity in health and well-being outcomes across the nation are the principle objectives of RWJF and other researchers.  As a representative of the CDC I will share our agency’s perspective on the new COH framework measures and related work on developing national metrics and discuss complementary efforts within the federal government.

Learning Areas:

Biostatistics, economics
Ethics, professional and legal requirements
Public health or related organizational policy, standards, or other guidelines

Learning Objectives:
Explain the RWJ culture of health framework and measures. Discuss the CDC approach to this framework and its efforts to identify and use related measures. Analyze the evolving conditions within the nation which make this discussion and corresponding actions steps so timely.

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am the Associate Director for Policy at the CDC, overseeing the agency’s central policy-making activities. Previously I was both a state health commissioner (6 years) and city health executive director (9 years) and the director of a university research institute.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.